Investigating the impact of Equol on brain health and Alzheimer's risk in women.
Official title: 7T Vascular and Molecular Imaging of SVD: Sex, Equol, and Risk of Alzheimer’s Disease
Funded at University of Pittsburgh at Pittsburgh · NIH-11171420 · Data updated 2026-11-12
This study is looking at how small blood vessel problems in the brain and Alzheimer's disease affect women, especially since they might be more at risk, and it will explore whether a natural compound called Equol can help protect brain health and lower the chances of dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $647,739 |
| NIH project number | 5R01AG085566-02 |
| Project ID | NIH-11171420 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are older women, particularly those who have experienced menopause and may be at risk for Alzheimer's disease.
✕Less likely to help
Patients who are not women or who are younger than the typical age of menopause may not benefit from this research.
What this research studies
This research focuses on understanding how cerebral small vessel disease (SVD) and Alzheimer's disease (AD) interact, particularly in women who may be at higher risk due to sex-specific factors. The study will utilize advanced 7T vascular and molecular imaging techniques to assess changes in brain blood vessels and neurochemical markers associated with aging. By examining the effects of Equol, a compound with potential protective benefits for blood vessels, the research aims to identify ways to improve cerebrovascular health and reduce the risk of dementia. Patients may be involved in assessments that help clarify these relationships and the role of Equol in brain health.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease in women.
How similar studies have gone: Previous research has shown promising results in understanding the relationship between cerebrovascular health and Alzheimer's disease, but this specific approach using 7T imaging and Equol is relatively novel.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Wu, Minjie — University of Pittsburgh at Pittsburgh
- Study coordinator: Wu, Minjie
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.